employees and contractors, 207 Peruvians, and 8 Venezuelans and Bolivians). Most staff are based at a 37,000-square-foot laboratory and animal care facility on the Peruvian naval hospital compound in metropolitan Lima (DoD-GEIS, 2007a). This facility contains three biosafety level 3 (BSL-3) laboratories, including one dedicated to animal investigations. NMRCD also has a new 5,000-square-foot facility on the base of the Peruvian Navy clinic in Iquitos, Peru. The mission of the detachment includes support for vaccine and drug development, evaluation of rapid diagnostics, and surveillance of emerging and re-emerging infectious diseases. The programs and collaborations of NMRCD extend through most of the countries of South and Central America (see Figure 7-1).
The DoD-GEIS program at NMRCD is in alignment with the strategic goals of the overall DoD-GEIS mission as described in the recent five-year plan for the years 2005-2009. DoD-GEIS has identified the following goals as integral to its mission in South America: outbreak response preparation, detection, investigation, microbial agent identification, and communicable